#API Holdings Unlisted Share

[bharatinvest64]

Investing in Potential: The Pros and Cons of Buying Unlisted Shares

In the ever-evolving landscape of investing, unlisted shares have emerged as a captivating avenue for those seeking high-growth opportunities. These shares, also known as private shares, represent ownership in companies that are not listed on any stock exchange. While investing in unlisted shares holds the promise of substantial returns, it's essential to weigh the pros and cons before diving into this intriguing market. In this blog post, we delve into the advantages and disadvantages of buying unlisted shares, along with insights into some noteworthy options in the market today.

Pros of Buying Unlisted Shares

High Growth Potential: Unlisted companies often operate in dynamic sectors with significant growth prospects. Investing in these companies at an early stage can potentially yield substantial returns as they scale their operations and capture market share. Companies like Pharmeasy and Bira, known for their innovative business models and rapid expansion, exemplify the high growth potential of unlisted shares.

Early Access to Promising Ventures: Buying unlisted shares allows investors to gain early access to promising ventures before they go public. This early-stage investment opportunity provides a chance to participate in the growth story of innovative startups and disruptors across various industries. For instance, Sterlite Power Transmission, a leading player in the power transmission sector, offers unlisted shares that provide investors with exposure to India's infrastructure growth story.

Diversification: Including unlisted shares in an investment portfolio enables diversification beyond traditional asset classes such as stocks and bonds. By diversifying across listed and unlisted shares, investors can spread their risk and potentially enhance their overall portfolio returns. Oyo, a global hospitality unicorn, presents an opportunity for investors to diversify their portfolio into the hospitality and travel sector through its unlisted shares.

Cons of Buying Unlisted Shares

Lack of Liquidity: One of the significant drawbacks of investing in unlisted shares is the lack of liquidity. Unlike publicly traded stocks, unlisted shares are not readily tradable on stock exchanges, making it challenging to buy or sell them at will. Investors may face difficulties in exiting their investments or finding buyers willing to purchase unlisted shares at fair prices.

Limited Information and Transparency: Unlisted companies are not subject to the same regulatory disclosure requirements as publicly traded companies. As a result, investors may have limited access to information about the company's financial performance, operations, and management. This lack of transparency can make it challenging to conduct thorough due diligence and assess the true value and risks associated with unlisted shares.

Higher Risk Profile: Investing in unlisted shares carries inherently higher risks compared to investing in publicly traded stocks. These risks stem from factors such as limited liquidity, higher volatility, and the potential for loss of investment capital. While some unlisted companies may have promising growth prospects, others may fail to deliver returns or even go bankrupt, leading to complete loss of investment.

Noteworthy Options in the Unlisted Shares Market

Pharmeasy Share Price: Pharmeasy, a leading online pharmacy platform in India, has garnered attention for its innovative healthcare solutions and rapid growth trajectory. Despite being unlisted, Pharmeasy's shares attract investor interest due to the company's strong market position and potential for further expansion in the digital healthcare space.

Sterlite Power Transmission Share Price: Sterlite Power Transmission, a pioneer in the power transmission and infrastructure sector, offers unlisted shares to investors looking to capitalize on India's growing demand for electricity and infrastructure development. With a robust project pipeline and strategic investments, Sterlite Power Transmission presents an opportunity for investors bullish on the infrastructure sector.

Oyo Share Price: Oyo, a global hospitality unicorn, continues to disrupt the hotel industry with its innovative business model and technology-driven approach. Despite facing challenges, Oyo's unlisted shares remain sought after by investors optimistic about the long-term prospects of the hospitality and travel sector.

NSE Unlisted Share Price: NSE, India's leading stock exchange, also offers unlisted shares to investors seeking exposure to the financial services industry. As a key player in the Indian capital markets, NSE's unlisted shares provide an opportunity to participate in the growth of India's financial ecosystem.

Bira Share Price: Bira 91, a popular craft beer brand, has established itself as a prominent player in India's alcoholic beverages market. With its unique brand positioning and product offerings, Bira's unlisted shares attract investors looking to capitalize on shifting consumer preferences and the rise of premium alcoholic beverages.

In conclusion, investing in unlisted shares offers the potential for high returns but comes with its own set of risks and challenges. While unlisted shares provide access to early-stage investment opportunities and diversification benefits, investors must carefully evaluate the risks and conduct thorough due diligence before making investment decisions. By weighing the pros and cons and staying informed about market trends and company fundamentals, investors can navigate the unlisted shares market effectively and capitalize on promising investment opportunities.

[generalwombatexpert]

According to persons with knowledge of the situation, the largest online pharmacy PharmEasy has notified its board and investors that it intends to raise around Rs 2,400 crore ($291.5 million) through a rights offering at a 90% discount to its highest stock price in order to pay back a loan from Goldman Sachs. According to documents reviewed by ET, API Holdings, the parent company of the unlisted PharmEasy, would issue fresh shares at a price of Rs 5 per share. In 2021, API raised capital at Rs 50 per share.

[delistedshares]

https://delistedstocks.in/current-offerings/api-holdings-pharmeasy-limited/

Navigating the world of unlisted stocks, particularly PharmEasy shares, requires a strategic approach. By leveraging platforms like DelistedStocks, investors can effectively buy or sell PharmEasy unlisted shares, taking into account key factors such as historical share prices and current market trends. Keep a close eye on PharmEasy share prices and adhere to regulatory guidelines to ensure a successful and compliant investment experience on DelistedStocks.

[delistedstocks]

Get the Live Updates on Pharm Easy Parent company- API Holdings Unlisted shares. Do Live chat for Buying and Selling of Unlisted Shares of API Holdings (Pharm Easy)

[bharatinvest64]

PharmaEasy's Growth Story: Unlisted Shares as a Testament to Success

Introduction to PharmaEasy

PharmaEasy, the leading online pharmacy and healthcare platform in India has been making waves in the market with its exceptional growth story. With a commitment to providing accessible and affordable healthcare solutions to millions of people across the country, PharmaEasy has become synonymous with convenience and reliability. In this blog post, we will delve into PharmaEasy's journey from its humble beginnings to becoming a game-changer in the pharmaceutical industry. We will also explore the significance of unlisted shares in the stock market and how PharmaEasy's unlisted shares have performed over time. So sit back, relax, and join us on this exciting ride as we unravel PharmaEasy's success story!

History and Growth of the Company

PharmaEasy, a leading healthcare technology platform in India, has an impressive history and a remarkable journey of growth. Founded in 2015 by Dharmil Sheth, Dr. Dhaval Shah, and Hardik Dedhia, the company started with a vision to make healthcare accessible and affordable for all. In its early years, PharmaEasy focused on providing online medicine delivery services to customers across Mumbai. With its user-friendly app and efficient delivery network, the company quickly gained traction and expanded its operations to other cities. As time went on, PharmaEasy diversified its offerings by partnering with local pharmacies to provide diagnostic tests as well as consultations with doctors through telemedicine. This move not only increased convenience for users but also positioned PharmaEasy as a one-stop solution for all their healthcare needs. The year 2020 was particularly significant for PharmaEasy as it witnessed unprecedented growth amidst the COVID-19 pandemic. The demand for online healthcare services skyrocketed during this period, and PharmaEasy emerged as a lifeline for many patients who were unable or reluctant to visit physical stores. To further strengthen its position in the market, PharmaEasy went on an acquisition spree. It acquired Medlife - another prominent player in the e-pharmacy space - thereby expanding its customer base exponentially. Today, after several rounds of funding and strategic partnerships with major investors like API Holdings (parent company), CDPQ (Caisse de dépôt et placement du Québec), TPG Growth among others; Pharmeasy has become one of India's largest digital health platforms serving millions of customers nationwide. With such rapid growth over the years fueled by innovation and customer-centricity at its core; it comes as no surprise that PharmaEasy's unlisted shares have become highly sought after by investors looking to capitalize on the success story that continues unfolding before our eyes.

Unlisted Shares and Their Importance in the Stock Market

Unlisted shares play a significant role in the stock market, offering investors unique opportunities and potential for high returns. Unlike listed shares that are traded on exchanges, unlisted shares belong to companies that have not yet gone public or chosen to be listed. One of the key advantages of investing in unlisted shares is the potential for early entry into promising companies. Investors who can identify these opportunities early on may benefit from substantial gains once the company goes public. Unlisted shares also provide diversification benefits as they often represent companies from various sectors and industries. Moreover, unlisted shares allow investors to participate in pre-IPO rounds, enabling them to invest at a lower valuation before the company's value potentially increases upon listing. This can result in higher returns compared to those who invest only after an IPO. Additionally, investing in unlisted shares allows individuals to support innovative startups and contribute directly to their growth story. By providing capital during their early stages, investors help fuel innovation and entrepreneurial endeavors. However, it is important to note that investing in unlisted shares comes with its own set of risks. These investments tend to be illiquid since there is no established market for trading them like listed stocks. Additionally, information about these companies may be limited or difficult to obtain compared to publicly listed firms. While investing in unlisted shares offers unique opportunities for high returns and supporting promising businesses' growth journey; it requires careful evaluation of the risks involved alongside thorough research and due diligence before making any investment decisions

PharmaEasy's Unlisted Shares and their Performance

One of the key indicators of a company's success is how its shares perform in the stock market. In the case of PharmaEasy, its unlisted shares have been attracting significant attention. These unlisted shares are traded privately among investors, providing an opportunity to own a stake in the company before it goes public. The performance of PharmaEasy's unlisted shares has been nothing short of impressive. Investors who had the foresight to invest in these shares early on have reaped substantial returns. As more people become aware of PharmaEasy's growth potential, demand for its unlisted shares continues to rise. What sets PharmaEasy apart is its innovative approach to healthcare delivery. With a robust digital platform that connects patients with pharmacies and diagnostic centers, they have revolutionized how people access medical services. This unique business model has contributed to their rapid growth and increasing valuation. Investing in PharmaEasy's unlisted shares not only provides an opportunity for financial gains but also allows investors to support a company that is making a positive impact on society. By investing in this promising healthcare tech start-up, individuals can align their investment goals with their values. As more investors recognize the potential value of owning PharmaEasy's unlisted shares, it further solidifies the company as an attractive investment option within the pharmaceutical industry. The growing interest from both institutional and retail investors speaks volumes about confidence in PharmaEasy's prospects. In conclusion (not part of my answer), PharMaesy has established itself as one of India’s leading online pharmacy platforms with tremendous growth potential ahead. Its performance in terms of revenue generation and customer acquisition has attracted investor interest, resulting in strong demand for its unlisted shares. As PharMaesy continues expanding into new markets and diversifying its offerings through strategic partnerships, it will likely continue demonstrating strong performance across various metrics, making it an enticing prospect for those interested i the Indian e-commerce sector.

Future Plans and Expansion for PharmaEasy

PharmaEasy, the leading online pharmacy platform in India, has achieved remarkable success since its inception. With a strong customer base and partnerships with top pharmaceutical companies, the company is now looking towards expanding its services and reaching even greater heights. One of PharmaEasy's key plans is to enhance its product offerings. The company aims to provide a wider range of healthcare products including medical devices, personal care items, wellness supplements, and more. By diversifying their offerings, PharmaEasy aims to become a one-stop solution for all healthcare needs. Additionally, PharmaEasy is focused on expanding its reach to smaller towns and rural areas across India. The company recognizes the need for affordable and accessible healthcare options in these regions and seeks to bridge this gap by providing doorstep delivery of medications. This expansion will not only benefit underserved communities but also contribute significantly to the company's growth. Another crucial aspect of PharmaEasy's plans is technological innovation. The company aims to leverage cutting-edge technologies such as artificial intelligence (AI) and machine learning (ML) algorithms to improve user experience on their platform. By investing in technology-driven solutions like predictive analysis for inventory management or personalized recommendations based on user data, Pharmeasy strives to offer seamless experiences that meet individual customer needs. Furthermore, international expansion is also part of PharmaEasy's growth strategy. As they continue to dominate the Indian market, they are exploring opportunities in neighboring countries where there may be similar demand for convenient medication delivery services.

Conclusion

PharmaEasy's growth story is truly remarkable, and its unlisted shares have played a significant role in reflecting the company's success. As part of API Holdings pharmeasy has established itself as a leading player in the healthcare industry by providing convenient access to medicines and other healthcare products. Through strategic partnerships, innovative technologies, and customer-centric approaches, PharmaEasy has experienced rapid expansion and impressive revenue growth. Its commitment to delivering quality service has earned it a loyal customer base and placed it at the forefront of India's e-pharmacy market. The performance of PharmaEasy's unlisted shares further reinforces its position as an attractive investment opportunity. With increasing investor interest in digital health platforms like PharmaEasy, these unlisted shares have become highly sought after. Looking ahead, PharmaEasy shows no signs of slowing down. The company has ambitious plans for future growth and aims to expand its services across more cities in India while also exploring opportunities beyond national borders. By continuously enhancing their offerings and leveraging technology advancements, they are well-positioned to seize new opportunities in the evolving healthcare landscape.

[bharatinvest64]

Pharmeasy Share Price Analysis: Is It a Good Investment?

Investing in shares, especially in the healthcare sector, has always been a topic of interest for many. One company that has caught the attention of investors is Pharmeasy. As we delve into the analysis of Pharmeasy's share price, we will also touch upon related aspects such as Pharmeasy's unlisted share price, the broader market for unlisted shares, and the share price of its parent company, API Holdings.

Understanding Pharmeasy

Pharmeasy is one of India's leading online healthcare platforms, offering services such as medicine delivery, diagnostic tests, and teleconsultations. The company's innovative approach and rapid growth have made it a popular choice among consumers and investors alike.

Current Status of Pharmeasy Share Price

As of now, Pharmeasy's shares are not listed on any public stock exchange. This means that investors cannot buy or sell Pharmeasy shares through traditional stock markets. However, there is a vibrant market for unlisted shares where Pharmeasy's unlisted share price is actively traded.

What are Unlisted Shares?

Unlisted shares refer to the shares of companies that are not listed on any stock exchange. These shares are usually traded over-the-counter (OTC) and are often considered high-risk, high-reward investments. Investors in unlisted shares typically include venture capitalists, private equity firms, and sophisticated individual investors who seek substantial returns.

Pharmeasy Unlisted Share Price

The Pharmeasy unlisted share price has shown significant volatility, reflecting the company's dynamic business environment and investor sentiment. As the company continues to expand its services and market reach, the unlisted share price has become an important indicator of its growth potential.

Factors Influencing Pharmeasy Share Price

Several factors influence Pharmeasy's share price, both listed and unlisted:

Market Demand: The demand for Pharmeasy's services plays a crucial role. Higher demand can drive up the share price as it indicates strong business performance.

Competitive Landscape: The presence of competitors in the online healthcare space can impact Pharmeasy's market share and, consequently, its share price.

Regulatory Environment: Changes in healthcare regulations can affect the company's operations and profitability, influencing its share price.

Financial Performance: Pharmeasy's revenue, profit margins, and overall financial health are critical determinants of its share price.

Investor Sentiment: General market sentiment towards tech and healthcare stocks can also drive the share price up or down.

API Holding Share Price

API Holdings, the parent company of Pharmeasy, also plays a significant role in determining the latter's share price. API Holdings' financial performance, strategic decisions, and market position directly impact investor confidence in Pharmeasy.

Is Pharmeasy a Good Investment?

Pros of Investing in Pharmeasy

Growth Potential: Pharmeasy operates in a rapidly growing market with increasing demand for online healthcare services.

Strong Brand: The company has established itself as a reliable and trusted brand in the healthcare sector.

Innovative Solutions: Pharmeasy's focus on technology and innovation positions it well for future growth.

Cons of Investing in Pharmeasy

Market Risks: As an unlisted company, Pharmeasy's shares are subject to higher volatility and risk.

Regulatory Changes: The healthcare industry is highly regulated, and any changes in regulations could impact Pharmeasy's operations.

Competition: The online healthcare market is becoming increasingly competitive, which could affect Pharmeasy's market share and profitability.

Conclusion

Investing in Pharmeasy, particularly through its unlisted shares, can be a lucrative opportunity for those willing to take on higher risks for potentially higher returns. The Pharmeasy share price reflects the company's growth trajectory and market potential, making it an intriguing option for forward-looking investors. However, it is essential to conduct thorough research and consider the associated risks before making any investment decisions. As always, consulting with a financial advisor can help align investment choices with individual financial goals and risk tolerance.

[generalwombatexpert]

PharmEasy filed a DRHP with SEBI for an IPO worth Rs. 6250 crores. DRHP was filed on 11th November 2021 and it will raise funds via fresh equity issuance. Currently there is no fixed date for its IPO. You can buy and sell unlisted shares of PharmEasy (API Holdings) at Planify. Check live PharmEasy share price and all impotent financials of company at Planify.

[generalwombatexpert]

Discover PharmEasy current share price and learn how to invest in this pharmaceutical technology company. Explore Planify platforms and check everything including brokerage accounts, and investment strategies to purchase PharmEasy shares and potentially benefit from the growth in the healthcare sector. Visit Planify and read PharmEasy (API Holdings) research report to explore all information.

[generalwombatexpert]

Yes, any one can buy (API Holdings) PharmEasy unlisted shares from Planify Capital by using official website or download android & iOS application from store to invest directly. You must have demat account to buy Pre IPO shares & unlisted shares, no matter with which broker you have a demat account.

[generalwombatexpert]

Can You Buy PharmEasy (API Holdings) Unlisted Shares at Planify?

Any one can buy & sell PharmEasy (APi Holdings) unlisted shares at Planify Capital Limited. No matter from which broker you have opened your demat account. There is no need of different demat account for unlisted shares. For more info about PharmEasy shares visit Planify or download Planify application from android play store or iOS store.

[generalwombatexpert]

API Holdings (PharmEasy) Unlisted Share Price - IPO Review - Planify

Pharmeasy is the parent company of API Holdings and it has filed a DRHP with SEBI for an IPO worth Rs. 6250 crores. You can start buying & selling API Holdings unlisted Shares through visiting Planify which is India's largest private equity and investment platform where you can check all reviews and updates about its financial statements.

[generalwombatexpert]

There are three main reason behind the falling of  PharmEasy (API-Holdings) share price. 1. Tech Sell Off, 2. Troubles in launching IPO, 3. Breaking down the Valuation, 4. Demand & Supply. If you want know more about these details, go through Planify and find all information.

[trade-unlisted]

A Beginner’s Guide To Unlisted Shares

What are Unlisted Shares?

In simple terms, unlisted shares are shares of a company that hasn’t gone public yet. By purchasing the unlisted shares of a private company, you can invest in it even before its initial public offering (IPO). The Unlisted Saga – Unlisted companies have ambitious plans for rapid growth that aspire to take their business to the next level turning them into multi bagger growth opportunities for investors. 

Previously, access to Similarly, access to startups, earlystage, pre-IPO companies were previously limited to venture capitalists & angel investors.

There are multiple ways to acquire unlisted shares. There are multiple platforms offering such unlisted and Pre IPO shares. TradeUnlisted is one such platform. TradeUnlisted is the leading platform for buying and selling of Unlisted Stocks. To know more, visit www.tradeunlisted.com

Features of Unlisted Shares: 

Dematerialized: Similar to listed stocks, unlisted stocks are also transferred to your Demat account. You may monitor the status of the unlisted shares that you have purchased through your depository participant account, in which they are available at face value.  

Growth Potential: You can now be a part of a private company’s growth since the start. Investors can buy shares in businesses that are either technologically or operationally new on unlisted markets. 

Liquidity: There is no restriction on buying or selling of unlisted shares until the IPO cut-off date, which is usually a week before the listing. However, after listing the SEBI norms shall be applicable to these shares. All unlisted shares go for a lock-in of 6 months from the date of listing, post which they can be traded like any other listed shares. 

Check the current Share Prices of Unlisted Companies in India: 

OYO (Oravel Stays Ltd)

Check OYO Unlisted Share Price

National Stock Exchange (NSE)

Check NSE Unlisted Share Price

PharmEasy (API Holdings Ltd)

Check PharmEasy Unlisted Share Price

Chennai Super Kings (CSK)

Check CSK Unlisted Share Price

Bira91 (B9 Beverages Pvt Ltd)

Check Bira91 Unlisted Share Price

Fino PayTech Ltd

Check Fino Unlisted Share Price

BoAt (Imagine Marketing Services Pvt Ltd)

Check Boat Unlisted Share Price

HDFC Securities Ltd

Check HDFC Securities Unlisted Share Price

Kurlon Enterprise Ltd

Check Kurlon Unlisted Share Price

Aricent Technologies (Holdings) Ltd

Check Aricent Unlisted Share Price

Capgemini Technology Services India Ltd

Check Capgemini Unlisted Share Price

NCL Buildtek Ltd

Check NCL Unlisted Share Price

Merino Industries Ltd

Check Merino Unlisted Share Price

Hexaware Technologies

Check Hexaware Unlisted Share Price

Capital Small Finance Bank Ltd

Check Capital Small Finance Bank Unlisted Share Price

Indofil Industries Ltd

Check Indofil Unlisted Share Price

Signify Innovations India Ltd

Check Signify Unlisted Share Price

Nayara Energy

Check Nayara Energy Unlisted Share Price

Hira Ferro Alloys Ltd

Check Hira Unlisted Share Price

Sterlite Power Transmission Ltd

Check Sterlite Power Unlisted Share Price

Carrier Air-Conditioning & Refrigeration Ltd

Check Carrier Unlisted Share Price

Axles India Ltd

Check Axles Unlisted Share Price

Care Health Insurance Ltd

Check Care Health Unlisted Share Price

Cochin International Airport Ltd (CIAL)

Check CIAL Unlisted Share Price

Elofic

Check Elofic Unlisted Share Price

Epiroc Mining India Ltd

Check Epiroc Unlisted Share Price

Frick India Ltd

Check Frick Unlisted Share Price

HDB Financial Services Ltd(HDBFS)

Check HDB Finance Unlisted Share Price

Hero FinCorp Ltd (HFCL)

Check Hero Fin Corp Unlisted Share Price

ICL Fincorp Ltd (ICL)

Check ICL Fin Corp Unlisted Share Price

India Carbon Ltd (ICL)

Check ICL Carbon Unlisted Share Price

Kannur International Airport

Check Kannur Unlisted Share Price

Lava International Ltd

Check Lava Unlisted Share Price

Maharashtra Knowledge Corporation Ltd (MKCL)

Check MKCL Unlisted Share Price

Metropolitan Stock Exchange Of India Ltd (MSEI)

Check MSE Unlisted Share Price

Mohan Meakin Ltd (MML)

Check Mohan Maekin Unlisted Share Price

Motilal Oswal Home Finance Ltd (MOHFL)

Check Motilal Oswal Unlisted Share Price

Reliance Retail Ltd

Check Reliance Retail Unlisted Share Price

Studds Accessories Ltd

Check Studds Unlisted Share Price

Tata Technologies

Check Tata Technologies Unlisted Share Price

Utkarsh CoreInvest Ltd

Check Utkarsh Core Unlisted Share Price

How to buy unlisted shares?

Trade Unlisted is a leading platform for buying and selling of unlisted stocks. TradeUnlisted makes the process of buying and selling unlisted shares seamless and easy.  

Select the company whose share you are willing to buy.

Select the ‘Invest now’ button on the company page. The unlisted stocks will be added to your cart. 

In the cart section, you will be required to enter the quantity of unlisted shares you want to purchase. 

Please note that the minimum cart value should be at least INR 5000. 

Next step is to select the payment method you wish to use. Company accepts payments via debit card, net banking and UPI. 

Post payment, the Relationship Manager will confirm the payment made by you and will ask you to share your Client Master List (CML) details. 

The shares will be credited in the demat account mentioned in the CML copy within the timeline mentioned in the Deal Contract Letter. 

In case you have any other questions, please feel free to call TradeUnlisted on (+91) 8958212121 or write a letter at contactus@tradeunlisted.com. 

Disclaimer: TradeUnlisted is a transactional platform. We are not a stock exchange or an advisory platform. Investments in unlisted products carry a risk and may not provide the anticipated returns and there is a possibility of losing the entire capital as well. There is no assurance of exit and listing date and no clarity whether the ipo will come or not. Unlisted shares go in a lock-in for 6 months from the date of allotment in the ipo. No one should rely solely on the information published or presented herein and should perform personal due diligence or consult with an independent third-party advisor prior to making any investment decisions. The information is obtained from secondary sources, we do not assure the accuracy of the same. The estimates and information is based on past performance, which cannot be regarded as an accurate indicator of future performance and results.

[trade-unlisted]

Explore Opportunities in Private Markets

The Unlisted Saga: Unlisted companies are those with ambitious plans for rapid growth that aspire to take their business to the next level. These make them multi bagger growth opportunities for investors. 

TradeUnlisted is a platform that facilitates such private market investments. It is the leading platform for buying and selling of Pre IPO and Unlisted Stocks. We have been credited to institutionalize the unlisted markets in India. Today, most of the global investment managers of India work with us for Unlisted and Pre IPO investment opportunities. 

Visit Trade Unlisted Website to buy and sell Unlisted and Pre IPO stocks. 

Below are some of our current top picks: 

OYO | Hospitality 

Quickest & easiest booking app: Booking to check-in takes only 3 clicks in 3 seconds.

OYO has emerged as the 3rd largest Hotel Chain in the world.

OYO turned EBITDA positive in Q1 FY23 and revenue grew by 18% in FY22. (Source: DRHP 2022)

Full-stack technology platform that drives a strong proposition for both patrons and customers, resulting in 1.5x-2.4x higher revenue than the industry average.

Buy OYO unlisted shares 

National Stock Exchange of India (NSE) | Stock Exchange 

NSE was incorporated in 1992 and captured the market in a span of 3 years and became the leading stock exchange with highest turnover since 1995. 

World’s largest derivatives exchange for the third consecutive year in 2021 

Sales & PAT growth at 27% and 35% CAGR over the last 3 years.

Buy NSE unlisted shares 

PharmEasy (API Holdings) | PharmaTech

India’s leading healthcare delivery platform with over 50% market share. 

Total revenue of INR 5,700+ Cr. in FY 2022. 

Served 5 million families in 22,000+ pin codes through its 80,000+ partners spread across the country. 

Buy API Holdings unlisted shares 

Chennai Super Kings (IPL team), Bira91 (Brewery) and Fino PayTech (Financial Services) are some of the other currently unlisted opportunities on TradeUnlisted. Visit Trade Unlisted Website , for more information on all unlisted opportunities. 

[generalwombatexpert]

Buy Sell PharmEasy Unlisted Shares at Trading Price.

Buy sell PharmEasy (API Holdings) unlisted shares at trading price from Planify capital which is India's largest private investment platform. You can invest in private equity of PharmEasy and get high returns. You must visit Planify official website & application to get complete process that how to make successful transaction. Before invest you should read research report of API Holdings which includes last year financial report and check total profit after tax.

[generalwombatexpert]

There is multiple option for you to check (API Holdings) PharmEasy Unlisted Share Price. First you can check through call or what's app, second you can check through email and third you can check through visiting Planify capital official website. Today's share price is ₹ 74 Per share.